Navigation Links
Eklin Signs Letter of Intent With ZONARE for Distribution of Zone Sonography(TM) z.one System
Date:12/10/2008

SANTA CLARA, Calif., Dec. 10 /PRNewswire/ -- Eklin Medical Systems, Inc. today announced it has signed a letter of intent with ZONARE Medical Systems, Inc., a developer of premium ultrasound systems, for the distribution of ZONARE's z.one ultrasound system to the equine veterinary care market in North America and select countries internationally. Eklin is a leading provider of digital radiography (DR), ultrasound, PACS (Picture Archiving and Communications Systems) and Practice Management Software (VIA) around the globe.

"ZONARE has had significant success in the human healthcare market with its award-winning z.one ultrasound platform," said Gary R. Cantu, chairman and CEO for Eklin. "We have been looking for a comprehensive, hand-held ultrasound system which could deliver high resolution imaging at a substantial price-to-value ratio for our equine clients. ZONARE's z.one ultrasound platform will help us fulfill this goal."

The z.one ultrasound system is a premium-quality, Convertible Ultrasound(TM) platform based on proprietary Zone Sonography(TM) technology. Veterinary care providers are able to easily convert the z.one system from a full-featured, cart-based system into a cutting-edge, hand-held ultrasound system without sacrificing image quality or performance. As a result, demanding clinical studies can be done in a variety of settings, including ambulatory care, with high diagnostic confidence and ease-of-use.

"We were extremely impressed with the image quality produced by this 5.5 pound, hand-held ultrasound system," said William J. Hornof, DVM, Diplomate ACVR, chief medical officer for Eklin. "The grayscale detail provides advanced soft tissue imaging which is important for equine tendon and ligament interrogation. The penetration and high-end color Doppler capabilities of the cardiac transducer will provide the ability to perform equine echocardiography examinations as well."

ZONARE has developed a wide variety of transducers providing the veterinary care provider with a wide variety of imaging options. For example, ZONARE's L14-5w transducer produces premium tendon and joint images for the equine patient. The P4-1c transducer offers cardiac function analysis and the T9-4 allows intercostal access in tight areas, such as between the ribs. Designed specifically for equine reproduction is ZONARE's high performance, reproductive probe. Numerous other transducers are also available.

Additionally, the z.one system's software-based architecture allows its performance to continue to improve as greater processing power becomes available. System software upgrades can be downloaded over the internet.

"The ZONARE technology not only delivers great value and premium image quality, but also offers many other advantages to the veterinary care market," said Cantu. "The upgradeable nature of Zone Sonography technology ensures a significant return on investment at a very economical price now and in the future."

About ZONARE Medical Systems, Inc.

ZONARE Medical Systems, Inc., based in Mountain View, Calif., develops, manufactures and commercializes premium compact ultrasound systems that combine its proprietary technology with an innovative physical design. Zone Sonography technology, ZONARE's unique patented approach to ultrasound imaging, is focused on bringing premium image quality, performance and features to a wide range of clinical settings. Additional information can be found at http://www.zonare.com.

Convertible Ultrasound and Zone Sonography are trademarks of ZONARE Medical Systems.

About Eklin Medical Systems, Inc.

With thousands of systems installed in private practices and universities around the globe, Eklin Medical Systems, Inc. is one of the world's leading providers of veterinary PACS, practice management software (VIA), ultrasound and digital radiography products. Clients include more than 90 percent of U.S. veterinary schools of medicine, such as UC Davis, Ohio State, University of Pennsylvania and Texas A&M. Numerous zoos and marine facilities, including San Diego, Los Angeles, Bronx, SeaWorld and the U.S. Navy Marine Mammal Training Center, also employ Eklin Technology. Eklin is a privately-held company with reported sales revenues in excess of $35 million in 2007 and is headquartered in Santa Clara, Calif. The company can be contacted at 800-819-5538 or visit http://www.eklin.com.

     Media Contact
     Laurie Hallwyler
     Eklin Medical Systems
     650-248-9081
     lhallwyler@eklin.com

'/>"/>
SOURCE Eklin Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Eklin Medical Surpasses 1,000th RapidStudy(R) Digital Radiography System Installation Featuring Canon DR Technology
2. Eklin Announces Acquisition of Ultrasource, Inc.
3. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
4. Eklin Medical Reports Record Revenues for 2007
5. VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China
6. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
7. Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes
8. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
9. NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance
10. Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
11. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):